欧洲整形外科医生视角下的医疗旅游:执业、并发症与政策调查
费用是患者跨境就医首要动因,委员会认证被视为最重要验证标准。ESPRAS据此提出四支柱政策框架。
要点
- 费用是患者跨境就医首要动因(49.8%),委员会认证是最重要验证标准(79.2%)。
- ESPRAS提出四支柱框架:医生注册、机构认证、强制并发症保险和统一指南。
核心结论
- 欧洲整形外科医生描述了一个碎片化格局:受监管的核心与不受监管的商业边缘并存。
- ESPRAS提出四支柱框架作为协调欧洲应对的基础。
研究设计与样本
- 250名来自36个国家的委员会认证整形外科医生应答,其中230/250(92.0%)持有国家或国际委员会认证。
主要发现
- 为国际患者实施的最常见手术为隆乳术(n=86)、乳房缩小/乳房固定术(n=82)和腹壁成形术(n=80)。
- 最常见并发症模式为伤口裂开/坏死(n=156)和感染(n=131)。
- 费用是患者首要动机(49.8%);79.2%认为委员会认证是最重要验证标准。
- 77.2%认为利润优先于患者安全是主要促进者相关风险。
关键数值与推荐
- 强制国际资格标准(35.6%)和更严格的促进者监管(23.6%)是最受支持的政策优先事项。
临床怎么用
- 整形与烧伤科医生接诊跨境手术并发症时,应关注腹壁成形术、隆乳术和抽脂术后的伤口裂开/坏死及感染。
- 术前评估可参考委员会认证作为患者选择境外医生的重要验证标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Demand for aesthetic surgery has risen rapidly, and the parallel growth in cross-border medical travel is increasingly burdening European health systems with imported complications. The perspective of board-certified plastic surgeons themselves-as both providers of cross-border care and managers of its complications-has not been systematically captured at a European level. METHODS: An anonymous online questionnaire (43 items across three thematic sections) was distributed by the European Society of Plastic, Reconstructive and Aesthetic Surgery (ESPRAS) to its member national societies between December 2025 and February 2026. The instrument addressed (A) the practice of surgeons treating international patients, (B) the management of complications from procedures performed abroad, and (C) safeguards and policy reform. Quantitative data were summarised descriptively; free-text responses were analysed thematically. RESULTS: Two hundred and fifty board-certified plastic surgeons from 36 countries responded; 230/250 (92.0%) held national or international board certification. The most common procedures performed for international patients were breast augmentation (n=86), breast reduction/mastopexy (n=82), and abdominoplasty (n=80). Eighty-nine per cent of respondents had managed complications of procedures performed abroad in the preceding five years; abdominoplasty (n=144), breast augmentation (n=106), and liposuction (n=76) predominated, with wound dehiscence/necrosis (n=156) and infection (n=131) the most frequent patterns. Cost was the most often cited primary motivation for patients (49.8%); 79.2% of respondents identified board certification as the single most important verification criterion, and 77.2% identified profit prioritisation over patient safety as the principal facilitator-related risk. Mandatory international qualification standards (35.6%) and stricter facilitator regulation (23.6%) were the most frequently endorsed policy priorities. CONCLUSIONS: European plastic surgeons describe a fragmented landscape in which a regulated core coexists with an unregulated commercial periphery. ESPRAS proposes a four-pillar framework-public surgeon registries, facility and facilitator accreditation, mandatory complication insurance, and harmonised European patient- and surgeon-facing guidelines-as the basis of a coordinated European response.
引用
- Demirdöver C, Henley M, Schaefer DJ, et al. Medical tourism in plastic surgery: A European survey on professional practices, perspectives, and challenges. J Plast Reconstr Aesthet Surg. 2026. PMID: 42566949. doi:10.1016/j.bjps.2026.07.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。